| 000 | 01645 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517220122.0 | ||
| 264 | 0 | _c20180730 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1768-3254 | ||
| 024 | 7 |
_a10.1016/j.ejmech.2018.05.025 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLing, Yong | |
| 245 | 0 | 0 |
_aDevelopment of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities. _h[electronic resource] |
| 260 |
_bEuropean journal of medicinal chemistry _cJun 2018 |
||
| 300 |
_a199-209 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aNAD(P)H Dehydrogenase (Quinone) _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aQuinolones _xchemical synthesis |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aYang, Qiu-Xing | |
| 700 | 1 | _aTeng, Yu-Ning | |
| 700 | 1 | _aChen, Shi | |
| 700 | 1 | _aGao, Wei-Jie | |
| 700 | 1 | _aGuo, Jing | |
| 700 | 1 | _aHsu, Pei-Ling | |
| 700 | 1 | _aLiu, Yue | |
| 700 | 1 | _aMorris-Natschke, Susan L | |
| 700 | 1 | _aHung, Chin-Chuan | |
| 700 | 1 | _aLee, Kuo-Hsiung | |
| 773 | 0 |
_tEuropean journal of medicinal chemistry _gvol. 154 _gp. 199-209 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejmech.2018.05.025 _zAvailable from publisher's website |
| 999 |
_c28432027 _d28432027 |
||